Jack F. Bukowski

Rheumatology
75 Francis St
Boston, MA 02115

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies.

Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: September 19, 2019
Showing 1-1 of 1

Last Updated: 09/26/2026